Company
United StatesPublic company, NASDAQ: PTNPalatin Technologies, Inc. (NASDAQ: PTN), East Windsor, NJ – FDA Inspections
Inspection records and compliance data for Palatin Technologies, Inc. in East Windsor, New Jersey. 1 FDA inspection on record, last inspected December 16, 2022. Publicly traded as NASDAQ: PTN.
Company Profile
This profile covers Palatin Technologies, Inc. based in East Windsor, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected December 16, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 16, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1195023 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Palatin Technologies, Inc.
Stock ticker
PTN
Exchange
NASDAQ
Share price
$5.90
Market cap
$10.5M
Price as of
November 6, 2026
FEI Number
3001642225
Address
4b Cedarbrook Dr, East Windsor, New Jersey 08512, United States
Country
United States
ID: c2d81674-b12f-4c26-80f1-ebdb67960e8b